# Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/azienda-socio-sanitaria-territoriale-grande-ospedale-metropolitano-niguarda/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 54.8 |
| Citations | 1,229,734 |
| City | Milan |
| Country | IT |
| Description | Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda is a research organisation in Milan, IT. OpenAlex records 14,726 works and 1,229,734 citations for it. 3,144 researchers list it as their most recent affiliation. |
| Homepage | https://www.ospedaleniguarda.it |
| OpenAlex ID | https://openalex.org/I4210094195 |
| Researchers | 3,144 |
| ROR ID | https://ror.org/00htrxv69 |
| Type | healthcare |
| Works | 14,726 |

## University papers

Showing 12 of 16.

- [Expert consensus document on arterial stiffness: methodological issues and clinical applications](https://scholariq.org/papers/expert-consensus-document-on-arterial-stiffness-methodological-issues-and/)
- [Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy](https://scholariq.org/papers/baseline-characteristics-and-outcomes-of-1591-patients-infected-with-sars-cov-2/)
- [Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)](https://scholariq.org/papers/cardiac-involvement-in-a-patient-with-coronavirus-disease-2019-covid-19/)
- [Albumin Replacement in Patients with Severe Sepsis or Septic Shock](https://scholariq.org/papers/albumin-replacement-in-patients-with-severe-sepsis-or-septic-shock/)
- [Myocarditis and inflammatory cardiomyopathy: current evidence and future directions](https://scholariq.org/papers/myocarditis-and-inflammatory-cardiomyopathy-current-evidence-and-future/)
- [Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/dual-targeted-therapy-with-trastuzumab-and-lapatinib-in-treatment-refractory/)
- [Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy](https://scholariq.org/papers/management-of-acute-myocarditis-and-chronic-inflammatory-cardiomyopathy/)
- [Endothelial function and dysfunction. Part I](https://scholariq.org/papers/endothelial-function-and-dysfunction-part-i/)
- [Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis](https://scholariq.org/papers/clinical-presentation-and-outcome-in-a-contemporary-cohort-of-patients-with/)
- [Age and Multimorbidity Predict Death Among COVID-19 Patients](https://scholariq.org/papers/age-and-multimorbidity-predict-death-among-covid-19-patients/)
- [Hospital-Acquired Infections in Critically Ill Patients With COVID-19](https://scholariq.org/papers/hospital-acquired-infections-in-critically-ill-patients-with-covid-19/)
- [Eosinophilic Myocarditis](https://scholariq.org/papers/eosinophilic-myocarditis/)

## University top topics

Showing 8 of 25.

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.